Jupiter European Income Units
At a glance
| Initial charge | 5.00% |
|---|---|
| Initial saving | 4.75% |
| Annual charge | 1.50% |
| Annual saving | 0.250% ² |
| Total Expense Ratio | 1.80% |
| Launch date | 03-08-1987 |
| Launch price | £0.50 |
| Sector | Europe Excluding UK |
| Fund size | £796 million |
| Number of holdings | 36 |
| Fund type | Unit Trust |
| Type of units | Income |
Ways to Invest
Find out how to invest in this fundHL Research - Our view on this Fund
The European economy has followed the other Western economies and slowed this year in reaction to the credit crunch. Despite a challenging environment, Alex Darwell continues to focus on companies that he believes should perform throughout the business cycle. These include the likes of Novozyme, a leading manufacturer of enzymes which has a track record of strong sales growth.
Full research
About the Fund Manager
Alex Darwall
Located in: London
Alex Darwall trained as an investment analyst with de Zoete & Bevan (BZW) before moving to Enskilda Securities in Paris in 1987, where he became head of French equity research. He joined Goldman Sachs in London in 1992, again as a French equity analyst. In 1995 moved to Jupiter to run the European portion of a number of segregated pension fund accounts, subsequently taking responsibility for other accounts including County Council pension funds (European portion). At the start of 1999 he took over the management of the Jupiter European Investment Trust, and subsequently the roll over vehicle the Jupiter European Opportunities Trust which launched in November 2000. In January 2001 he became lead Fund Manager for the Jupiter European Fund. Alex is also head of the European Team and a Director of Jupiter International Group.
Income details
| Historic yield | 0.60% |
|---|---|
| Income paid | Annually |
| Type of payment | Dividend |
All yields are variable and not guaranteed. There is currently no yield information available for this fund.
Distribution dates
| Ex-dividend date | 01 July 2009 |
|---|---|
| Payment date ³ | 31 August 2009 |
Top 10 holdings
| Novo Nordisk A/S B | 10.06% |
|---|---|
| Novozymes A/S B | 10.02% |
| Reed Elsevier N.V. Cert. | 8.43% |
| Neopost | 8.33% |
| Syngenta AG | 5.32% |
| Compagnie Generale de Geophysique - Veritas | 5.23% |
| Dassault Systemes S.A. | 4.90% |
| Fresenius Pfd | 4.55% |
| Koninklijke Vopak N.V. | 3.96% |
| Euler Hermes | 3.17% |
Top 10 sectors
| Pharmaceuticals & Biotechnology | 22.45% |
|---|---|
| Media | 8.86% |
| Technology Hardware & Equipment | 8.33% |
| Chemicals | 7.73% |
| Oil Equipment, Services & Distribution | 6.66% |
| Health Care Equipment & Services | 5.70% |
| Software & Computer Services | 4.90% |
| Bonds | 4.70% |
| Banks | 4.46% |
| Industrial Transportation | 3.96% |
Top 10 countries
| France | 31.84% |
|---|---|
| Denmark | 20.07% |
| Netherlands | 13.82% |
| Switzerland | 12.28% |
| Germany | 9.54% |
| Norway | 5.59% |
| Spain | 2.20% |
| Finland | 2.09% |
| Sweden | 1.50% |
| Luxembourg | 0.43% |
² Annual saving is not available in the SIPP.
³ If you elect to receive the income from a Vantage ISA, Fund or Share Account, we will collect any dividends for you and then pay them directly into your bank account within the first 10 working days of the following month.
Last valuation as at 07-01-2009. Data accurate as at 30/11/2008.
